BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16460390)

  • 1. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
    Miller M
    J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL
    Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A
    Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin excess and hyponatremia.
    Pham PC; Pham PM; Pham PT
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP; Balk RA
    Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia: current treatment strategies and the role of vasopressin antagonists.
    Cawley MJ
    Ann Pharmacother; 2007 May; 41(5):840-50. PubMed ID: 17405824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y; Fujimori A; Sudoh K; Sasamata M
    Curr Opin Pharmacol; 2007 Apr; 7(2):124-9. PubMed ID: 17292670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M
    Geriatrics; 2007 Jul; 62(7):20-6. PubMed ID: 17620018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of vasopressin receptor antagonists in heart failure resulting in hospitalization.
    De Luca L; Orlandi C; Udelson JE; Fedele F; Gheorghiade M
    Am J Cardiol; 2005 Dec; 96(12A):24L-33L. PubMed ID: 16399090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia in neurologic patients: consequences and approaches to treatment.
    Diringer MN; Zazulia AR
    Neurologist; 2006 May; 12(3):117-26. PubMed ID: 16688013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for hyponatremia in heart failure.
    Goldsmith SR
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S15-8. PubMed ID: 20653706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
    Rosner MH; Ronco C
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.